Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of Colorado, a body”

255 pharma patents match "The Regents of the University of Colorado, a body" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 255
Index total 30,257
Page 11 / 11

Quick answer

This filtered view shows 255 pharmaceutical patents matching "The Regents of the University of Colorado, a body" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

255 results for “The Regents of the University of Colorado, a body” · 30,257 patents in full index Clear search

  1. US 8318490

    Prelamin A pre peptide as a universal stem cell differentiation signal

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 27, 2012 · Expires Nov 22, 2032

    granted
  2. US 8282963

    Methods for extracting platelets and compositions obtained therefrom

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted
  3. US 8221763

    Yeast-antigen compositions and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  4. US 8163509

    Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  5. US 8138312

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted
  6. US 8093286

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Jan 10, 2012 · Expires Jan 5, 2032

    granted
  7. US 8080578

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  8. US 8057807

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted
  9. US 8039001

    Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted
  10. US 8017321

    Gefitinib sensitivity-related gene expression and products and methods related thereto

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted
  11. US 7976851

    Non-toxic biofilm inhibitor

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted
  12. US 7678824

    Methods for treatment with bucindolol based on genetic targeting

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  13. US 7560265

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted
  14. US 7361355

    Mutant forms of cholera holotoxin as an adjuvant

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 22, 2008 · Expires Apr 17, 2028

    granted
  15. US 7285281

    Mutant forms of cholera holotoxin as an adjuvant

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted